Article Text
Abstract
Objective Poor metabolic health and unhealthy lifestyle factors have been associated with risk and severity of COVID-19, but data for diet are lacking. We aimed to investigate the association of diet quality with risk and severity of COVID-19 and its interaction with socioeconomic deprivation.
Design We used data from 592 571 participants of the smartphone-based COVID-19 Symptom Study. Diet information was collected for the prepandemic period using a short food frequency questionnaire, and diet quality was assessed using a healthful Plant-Based Diet Score, which emphasises healthy plant foods such as fruits or vegetables. Multivariable Cox models were fitted to calculate HRs and 95% CIs for COVID-19 risk and severity defined using a validated symptom-based algorithm or hospitalisation with oxygen support, respectively.
Results Over 3 886 274 person-months of follow-up, 31 815 COVID-19 cases were documented. Compared with individuals in the lowest quartile of the diet score, high diet quality was associated with lower risk of COVID-19 (HR 0.91; 95% CI 0.88 to 0.94) and severe COVID-19 (HR 0.59; 95% CI 0.47 to 0.74). The joint association of low diet quality and increased deprivation on COVID-19 risk was higher than the sum of the risk associated with each factor alone (Pinteraction=0.005). The corresponding absolute excess rate per 10 000 person/months for lowest vs highest quartile of diet score was 22.5 (95% CI 18.8 to 26.3) among persons living in areas with low deprivation and 40.8 (95% CI 31.7 to 49.8) among persons living in areas with high deprivation.
Conclusions A diet characterised by healthy plant-based foods was associated with lower risk and severity of COVID-19. This association may be particularly evident among individuals living in areas with higher socioeconomic deprivation.
- COVID-19
- diet
- dietary factors
- infectious disease
Data availability statement
The diet quality data used for this study are held by the department of Twin Research at Kings’ College London. The data can be released to bona fide researchers using our normal procedures overseen by the Wellcome Trust and its guidelines as part of our core funding (https://web.www.healthdatagateway.org/dataset/fddcb382-3051-4394-8436-b92295f14259). Zoe Platform data used in this study is available to researchers through UK Health Data Research using the following link:https://web.www.healthdatagateway.org/dataset/fddcb382-3051-4394-8436-b92295f14259. The diet quality data used for this study are held by the department of Twin Research at Kings’ College London. The data can be released to bona fide researchers using our normal procedures overseen by the Wellcome Trust and its guidelines as part of our core funding. We receive around 100 requests per year for our datasets and have a meeting three times a month with independent members to assess proposals. Application is via https://twinsuk.ac.uk/resources-for-researchers/access-our-data/. This means that the data needs to be anonymized and conform to GDPR standards.
Statistics from Altmetric.com
Significance of this study
What is already known on this subject?
Poor metabolic health and unhealthy lifestyle behaviours have been associated with higher risk and severity of COVID-19.
Improved nutrition, especially in the context of socioeconomic deprivation, has been shown to reduce the burden of certain infectious diseases in the past. Evidence on the association of diet quality with susceptibility and progression of COVID-19 is lacking.
What are the new findings?
A dietary pattern characterised by healthy plant-based foods was associated with lower risk and severity of COVID-19.
We found evidence of a synergistic association of poor diet and increased socioeconomic deprivation with COVID-19 risk that was higher than the sum of the risk associated with each factor alone.
The beneficial association of diet with COVID-19 risk seems particularly relevant among individuals living in areas of higher socioeconomic deprivation.
How might it impact on clinical practice in the foreseeable future?
Our study suggests that efforts to address disparities in COVID-19 risk and severity should consider specific attention to improve nutrition as a social determinants of health.
Introduction
Poor metabolic health linked to conditions such as obesity, type 2 diabetes or hypertension1 2 has been associated with increased risk and severity of COVID-19, and excess adiposity or preexisting liver disease might be causally associated with increased risk of death from COVID-19.3 4 Underlying these conditions is the contribution of a diet, which may be independently associated with COVID-19 risk and severity.
On the basis of prior scientific evidence, Diet Quality Scores (DQSs) have been developed to evaluate the healthfulness of dietary patterns.5–7 Dietary patterns capture the complexity of food intakes better than any one individual food item and offer the advantage of describing usual consumption of foods in typical diets.8 One such diet score is the healthful Plant-Based Diet Index (hPDI), which emphasises intake of healthy plant foods, such as fruits, vegetables and whole grains, and has been associated with lower risk of fatty liver, type 2 diabetes, and coronary artery disease.5 9 10
Adherence to healthful dietary patterns may also be a proximal manifestation of distal social determinants of health.11–13 Addressing adverse social determinants of health, such as poor nutrition, has been shown to reduce the burden of certain infectious diseases in the past,14 supporting calls for prioritising social determinants of health in the public health response to COVID-19. A previous study including ~3000 healthcare workers from 6 countries showed that plant-based or pescatarian diets were associated with lower odds of moderate-to-severe COVID-19.15 However, evidence on the association between diet quality and the risk and severity of COVID-19 in a general population is lacking, especially in the context of upstream social determinants of health. To address this evidence gap, we analysed data for 592 571 UK and USA participants from the smartphone-based COVID-19 Symptom Study,16 to prospectively investigate the association of diet quality with risk and severity of COVID-19 and its intersection with socioeconomic deprivation.
Materials and methods
Study design and participants
The COVID-19 Symptom Study is a smartphone-based study conducted in the UK and USA. Study design and sampling procedures have been published elsewhere.16 In brief, members of the general public were recruited through general media, social media outreach and direct invitations from investigators from the COronavirus Pandemic Epidemiology Consortium,16 a multinational collaboration including several large clinical and epidemiological cohort studies. This analysis included participants recruited from 24 March 2020 and followed until 2 December 2020. Participants who reported any symptoms related to COVID-19 prior to start of follow-up, or reported symptoms that classified them as having predicted COVID-19 within 24 hours of first entry, or who tested positive for COVID-19 at any time prior to start of follow-up or 24 hours after first entry were excluded. We also excluded participants younger than 18 years old, pregnant, and participants who logged only one daily assessment during follow-up. At enrolment, we obtained informed consent to the use of volunteered information for research purposes and shared relevant privacy policies and terms of use agreements.
Data collection procedures
Information on demographic factors was collected through standardised questionnaires at baseline,16 including age, sex, race, zip code or postcode, healthcare worker status, personal medical history including lung disease, diabetes, cardiovascular disease, cancer, kidney disease, and use of medications, and self-reported of a COVID-19 positive test or any COVID-19-related symptoms. During a follow-up, daily prompts queried for updates on interim symptoms, healthcare visits and COVID-19 testing results. Through software updates, a survey to examine usual diet and lifestyle habits during a prepandemic time frame (reference time February 2020) and during the pandemic (reference time July/August 2020) was launched between August and September 2020. Details about the diet and lifestyle survey are available in online supplemental file and published elsewhere.17 For this study, we used participant’s recall of their diet during February 2020, reflecting the period before the pandemic. A graph illustrating how and when diet and symptoms information was collected is provided in online supplemental figure 1.
Supplemental material
Assessment of diet quality
Diet quality was assessed using information obtained from an amended version of the Leeds Short Form Food Frequency Questionnaire18 that included 27 food items (online supplemental methods). The rationale to use this short-form food frequency questionnaire and not a full food frequency questionnaire was to limit participant burden by reducing time for completion. The accuracy and reliability of the short food frequency questionnaire has been assessed against a 217-item food frequency questionnaire and suggest that the short-form food frequency questionnaire is a reliable method of assessing diet quality.18
Participants were asked how often on average they had consumed one portion of each item in a typical week. The responses had eight frequency categories ranging from ‘rarely or never’ to ‘five or more times per day’. Diet quality was quantified using the validated hPDI score.5 To compute the hPDI, the 27 food items were combined into 14 food groups (online supplemental table 1). The original hPDI score included 18 food groups but nuts, vegetable oils, tea or coffee and animal fat were not specifically queried. Food groups were ranked into quintiles and given positive (healthy plant food groups) or reverse scores (less healthy plant and animal food groups). With positive scores, participants within the highest quintile of a food group received a score of 5, following on through to participants within the lowest quintile who received a score of 1. With reverse scores, this pattern of scoring was inverted. All component scores were summed to obtain a total score ranging from 14 (lowest diet quality) to 70 (highest) points. Criteria for generation of the hPDI are provided in online supplemental table 2.
As an additional method to quantify diet quality based on available diet information, we used the DQS.18 The DQS is a score for adherence to UK dietary guidelines and was computed from five broad categories including fruits, vegetables, total fat, oily fish and non-milk extrinsic sugars. Each component was scored from 1 (unhealthiest) to 3 (healthiest) points, with intermediate values scored proportionally (online supplemental table 3). All component scores were summed to obtain a total score ranging from 5 (lowest diet quality) to 15 (highest) points (online supplemental table 4).
Assessment of COVID-19 risk and severity
The primary outcome of this analysis was COVID-19 risk defined using a validated symptom-based algorithm,19 which provides similar estimates of COVID-19 prevalence and incidence as those reported from the Office for National Statistics Community Infection Survey.20 Details on the symptoms included in the predictive algorithm and corresponding weights are provided in online supplemental methods. In brief, the symptom-based approach uses an algorithm to predict whether a participant has been infected with SARS-CoV-2 on the basis of their reported symptoms, age and sex. To validate our case ascertainment, a subset of individuals who had reported symptoms in the COVID-19 Symptom Study application were invited to provide a copy of the test results. Among 235 participants, we found that self-reported COVID-19 testing yielded a positive predictive value of 88% and a negative predictive value of 94% for confirmed medical record results. The rationale for symptom-based classifier as a primary outcome was due to widespread difficulties obtaining testing during the early stages of the pandemic.21 Secondary outcomes were confirmed COVID-19 based on a self-report of a reverse transcription PCR positive test and COVID-19 severity. COVID-19 severity was ascertained based on a report of the need for a hospital visit which required (1) non-invasive breathing support, (2) invasive breathing support and (3) administration of antibiotics combined with oxygen support (online supplemental methods).
Statistical analysis
We elaborated a prespecified protocol including quality control procedures, definitions of exposures, outcomes and covariates, and statistical analysis plan prior to data analysis (online supplemental file). We summarised continuous measurements by using medians and percentiles 25th and 75th, and present categorical observations as frequency and percentages. The methods for classifying a priori selected covariates are provided in online supplemental file. Based on zip code (USA) or post code (UK) of residence, participants were assigned to country-specific community-level socioeconomic measures including socioeconomic deprivation and population density. For UK participants, we retrieved the education and income measures for the indices of multiple deprivation calculated by the Office of National Statistics from 2019 data aggregated to the 2011 Lower Super Output Areas.22 For participants in the USA, socioeconomic measures were generated using aggregated census data for up to 25 characteristics that have been used consistently to approximate neighborhood-level environments.23 Principal component analysis was used for census data reduction and seven variables were retained for the generation of the index. Loadings were obtained from the principal component analysis. The deprivation index was then standardised to have a mean of 0 and an SD of 1. Multiple imputations by chained equations with five imputations were used to impute missing values. Details about missingness prior to imputation are provided in online supplemental figure 2. All covariates in the primary analysis were included in the multiple imputation procedure, and estimates generated from each imputed dataset were combined using Rubin’s rules.24
Because diet information was collected for the prepandemic period, we conducted prospective analyses using Cox regression, in which follow-up time for each participant started 24 hours after first log-in to the time of predicted COVID-19 (or to time of secondary outcomes) or date of last entry prior to 2 December 2020, whichever occurred first. We modelled the DQS as a continuous variable and generated categories of the score based on quartiles of the distribution (quartile 1, low diet quality; quartiles 2–3, intermediate diet quality; quartile 4, high diet quality). Cox regression models stratified by calendar date at study entry, country of origin and 10-year age group were used to calculate HR and 95% CI for COVID-19 risk and severity (age-adjusted model 1). Model 2 was further adjusted for sex, race/ethnicity, index of multiple deprivation, population density and healthcare worker status. Model 3 was further adjusted for presence of comorbidities (diabetes, cardiovascular disease, lung disease, cancer, kidney disease), body mass index (BMI), smoking status and physical activity. A directed acyclic graph depicting a possible scenario that could explain the association between diet quality and COVID-19 risk and severity is provided in online supplemental figure 3. We verified the proportional hazards assumption of the Cox model by using the Schoenfeld residuals technique.25 Absolute risk was calculated as the percentage of COVID-19 cases occurring per 10 000 person-months in a given group. We used restricted cubic splines with four knots (at the 2.5th, 25th, 75th and 97.5th percentiles) to assess for non-linear associations between diet quality and COVID-19 risk.
In secondary analyses, we used a self-report of a positive test to define COVID-19 risk. For these analyses, we used inverse probability-weighted Cox models to account for predictors of obtaining country-specific testing. Inverse probability-weighted analyses included presence of COVID-19-related symptoms, interaction with a person with COVID-19, occupation as a healthcare worker, age group and race. Inverse probability-weighted Cox models were stratified by 10-year age group and date with additional adjustment for the covariates used in previous models. For severe COVID-19 analyses, we adjusted for the same covariates used in previous models. As an additional method to quantify diet quality we used the DQS and tested for associations between diet quality and COVID-19 risk and severity. In addition, we censored our analyses to cases that occurred after completing the diet survey to investigate potential bias due to time-varying confounding.
In subgroup analyses, we assessed the association between diet quality and COVID-19 risk according to comorbidities, demographic and lifestyle characteristics. We also classified participants according to categories of the DQS and socioeconomic deprivation (nine categories based on thirds of DQS and deprivation index) and conducted joint analyses for COVID-19 risk. The joint analysis was conducted to quantitatively estimate the combined association of diet and deprivation simultaneously with risk of COVID-19. We tested for additive interactions by assessing the relative excess risk due to interaction (RERI), and further examined the COVID-19 risk proportions attributable to diet, deprivation and to their interaction (online supplemental methods).26
We conducted sensitivity analyses to account for regional differences in the effective reproductive number (Rt) or other risk mitigating behaviours such as mask wearing. The Rt parameter denotes the number of additional persons infected, on average, by a single case and has been used as a measure of how quickly the virus is spreading and serves as a virulence proxy. For Rt analyses, we extracted US state-level information on Rt from the COVID-19 Tracking Project (https://covidtracking.com), for the period between March 2020 and January 2021. For the UK, we calculated Rt time-series for Scotland, Wales, and each of the National Health Service (NHS) regions in England, using a previously published methodology from our group.20 For these analyses, we defined community peak and nadir Rt time-windows as the period between 1 week before and 2 weeks after Rt was all-time high or low. Using censored time-windows, we tested the association between diet quality and COVID-19 risk after adjusting for the same confounders as included in model 3. For mask wearing analyses, we used survey data launched between June 2020 and until September 2020 on whether participants had worn a face mask when outside the house in the last week. Responses were categorised into two categories: participants who wore masks ‘none of the time or sometimes’, and those who reported wearing masks ‘most of time/always’ at least once. For mask wearing analyses, we included the same covariates as included in model 3.
Further, structural equation models were implemented to conduct a mediation analysis of BMI. For this analysis, diet quality and BMI were used as continuous variables. We estimated the relative contribution of BMI to the association between diet quality and COVID-19 risk and computed the proportion of total effect that was explained by indirect effects of BMI. Indirect effects were estimated by taking the product of the effect of the exposure on the mediator and the effect of the mediator on the outcome. To calculate the proportion of the mediated effect, we divided the indirect effect by the total effect. The direct effect, which is defined as the association of diet quality on COVID-19 risk through mechanisms independent of mediation, was estimated from regressing COVID-19 on diet quality.
Two-sided values of p<0.05 were considered statistically significant for main analyses. All statistical analyses were performed using R software, V.4.0.3 (R Foundation).
Patient and public involvement
No patients were directly involved in designing the research question or in conducting the research. No patients were asked for advice on interpretation or writing up the results. Results of the study will be shared with the public and patients directly via the ZOE symptom app, blog posts hosted on the https://covid.joinzoe.com/ website and webinars.
Results
Self-reported diet quality was evaluated in 647 137 survey responders, of which 54 566 were excluded due to prevalent COVID-19 (n=1555), presence of any symptoms at baseline (n=47 594), logged only once (n=1201), pregnancy (n=1129) or age under 18 years (n=3087; online supplemental figure 4). Baseline characteristics of the 592 571 participants included in this study according to categories of the hPDI score are shown in table 1. Participants in the highest quartile of the diet score (reflecting a healthier diet) were more likely than participants in the lowest quartile to be older, female, healthcare workers, of lower BMI, engage in physical activities ≥5 days/week and less likely to reside in areas with higher socioeconomic deprivation. Characteristics of participants from the COVID-19 Symptom Study according to diet survey participation are presented in online supplemental table 5. The hPDI score was normally distributed (online supplemental figure 5).
Over 3 886 274 person-months of follow-up, 31 815 COVID-19 cases were documented. Crude COVID-19 rates per 10 000 person-months were 72.0 (95% CI 70.4 to 73.7) for participants in the highest quartile of the diet score and 104.1 (95% CI 101.9 to 106.2) for those in the lowest quartile. The corresponding age-adjusted HR for COVID-19 risk was 0.80 (95% CI 0.78 to 0.83, table 2). Differences in the risk of COVID-19 persisted after adjustment for potential confounders. In fully adjusted models, the multivariable-adjusted HR for COVID-19 risk was 0.91 (95% CI 0.88 to 0.94) when we compared participants with high diet quality to those with low diet quality. We observed non-linear decreasing trends in the risk of COVID-19 with higher diet quality (p<0.001 for non-linearity), in which COVID-19 risk plateau among individuals with a DQS >50 (online supplemental figure 6). The association between diet quality and COVID-19 risk was consistent but attenuated in secondary analyses using the DQS score (HR 0.92; 95% CI 0.89 to 0.95; online supplemental table 6), and became non-significant in fully adjusted models (HR 1.00; 95% CI 0.97 to 1.03). We also investigated whether our primary findings were consistent in an analysis censored to cases that occurred after the completion of the diet survey. These analyses showed that high diet quality, compared with low diet quality, was associated with lower COVID-19 risk (multivariable-adjusted HR 0.88; 95% CI 0.83 to 0.93; online supplemental table 7).
In secondary analyses for COVID-19 risk based on a positive test, we showed that crude COVID-19 incidence rates per 10 000 person-months were 12.9 (95% CI 12.2 to 13.6) for individuals with high diet quality and 16.4 (95% CI 15.5 to 17.2) for individuals with low diet quality. The corresponding multivariable-adjusted HR for risk of COVID-19 was 0.82 (95% CI 0.78 to 0.86; table 2). For risk of severe COVID-19, crude incidence rates were lower for individuals reporting high diet quality compared with those with low diet quality (1.6 (95% CI 1.3 to 1.8) vs 2.1 (95% CI 1.9 to 2.5; per 10 000 person-months) table 2). In the fully adjusted model, high diet quality, as compared with low diet quality, was associated lower risk of severe COVID-19 with an an HR of 0.59 (95% CI 0.47 to 0.74; table 2).
In stratified analyses, the inverse association between diet quality and COVID-19 risk was more evident in participants living in areas of high socioeconomic deprivation and those reporting low physical activity levels (p<0.05; table 3). We found no significant effect modification for other characteristics such age, BMI, race/ethnicity or population density. When diet quality and socioeconomic deprivation were combined, there was a risk gradient with low diet quality and high socioeconomic deprivation. Compared with individuals living in areas with low socioeconomic deprivation and high diet quality, the multivariable-adjusted HR for risk of COVID-19 for low diet quality was 1.08 (95% CI 1.03 to 1.14) among those living in areas with low socioeconomic deprivation, 1.23 (95% CI 1.17 to 1.29) for those living in areas with intermediate socioeconomic deprivation, and 1.47 (95% CI 1.38 to 1.52) for those living in areas with high socioeconomic deprivation (figure 1). The joint association of diet quality and socioeconomic deprivation was higher than the sum of the risk associated with each factor alone (RERI=0.05 (95% CI 0.02 to 0.08); Pinteraction=0.005; online supplemental table 8). The proportion of contribution to excess COVID-19 risk was estimated to be 31.9% (95% CI 18.2% to 45.6%) to diet quality, 38.4% (95% CI 26.5% to 50.3%) to socioeconomic deprivation, and 29.7% (95% CI 2.1% to 57.3%) to their interaction. The absolute excess rate of COVID-19 per 10 000 person-months for lowest versus highest quartile of the diet score was 22.5 (95% CI 18.8 to 26.3) among persons living in areas with low socioeconomic deprivation and 40.8 (95% CI 31.7 to 49.8) among individuals living in areas with high deprivation (online supplemental figure 7).
We conducted a series of sensitivity analyses to further account for variation in Rt, mask wearing. For peak Rt censored analyses, crude COVID-19 rates per 10 000 person-months were 148.1 (95% CI 139.9 to 156.8) among participants with low diet quality and 92.9 (95% CI 86.6 to 99.5) for participants with high diet quality. The corresponding multivariable-adjusted HR was 0.84 (95% CI 0.76 to 0.92, figure 2). The same trend was observed for nadir Rt censored analyses, in which crude COVID-19 rates per 10 000 person-months were 67.1 (95% CI 61.7 to 73.0) among participants with low diet quality and 45.8 (95% CI 41.3 to 50.5) for participants with high diet quality (multivariable-adjusted HR 0.89; 95% CI 0.80 to 1.00, figure 2). We further adjusted our models for mask wearing. This analysis showed that high diet quality, as compared with low diet quality, was associated with lower risk of COVID-19 with an adjusted HR of 0.88 (95% CI 0.83 to 0.94; online supplemental table 9).
In a mediation analysis of BMI, we observed that BMI mediated 37% (95% CI 30% to 44%; p<0.001) of the effect of diet quality on COVID-19 risk, and that there was also evidence of a direct effect of diet and COVID-19 risk (HR 0.98: 95% CI 0.97 to 0.98; per 1 SD increase in hPDI; online supplemental table 10).
Discussion
In this large survey among UK and US participants prospectively assessing risk and severity of COVID-19 infection, we found that a dietary patterns characterised by healthy plant foods was associated with lower risk and severity of COVID-19. We observed a risk gradient of poor diet quality and increased socioeconomic deprivation that departed from the additivity of the risks attributable to each factor separately, suggesting that the beneficial association of diet with COVID-19 may be particularly evident among individuals with higher socioeconomic deprivation.
Our findings are aligned with preliminary evidence showing that improving nutrition could help reduce the burden of infectious diseases.12 14 27 Previous studies have shown that the administration of arachidonic or linoleic acid partially suppresses SARS-CoV-1 and coronavirus 229E viral replication,28 and that specific nutrients or dietary supplements associate with modest reductions in COVID-19 risk.29 Trace elements, vitamins (A, B6, B12, C, D, and E, and folate), amino acids, long-chain omega-3 fatty acids (docosahexaenoic and eicosapentaenoic) and non-nutrient-bioactive such as polyphenols have key roles in immune system function and cytokine release,30 and might partially explain some of the observed associations. Results from this observational study could expand previous single nutrient observations and highlight the beneficial association of healthy dietary patterns, which was most pronounced for risk of severe COVID-19. Our findings also concur with a comparative risk assessment study suggesting that a 10% reduction in the prevalence of diet-related conditions such as obesity and type 2 diabetes would have prevented ~11% of the COVID-19 hospitalisations that have occurred among US adults since November 2020.31
The association of healthy diet with lower COVID-19 risk appears particularly evident among individuals living in areas of higher socioeconomic deprivation. Our models estimate that nearly a third of COVID-19 cases would have been prevented if one of two exposures (diet and deprivation) were not present. While the population attributable risk is a population-specific calculation that is dependent on the prevalence of the exposure and its association with disease risk with an assumed causal effect, we acknowledge that our estimation of population attributable risk has several limitations. First, as with all the observational research, our estimates did not necessarily indicate causal effects. Second, estimated attributable risks are likely to change over time with the prevailing SARS-CoV-2 infection rate. However, our observations are consistent with data from ecological studies showing that people living in regions with greater social inequalities are likely to have higher rates of COVID-19 incidence and deaths.32 By generating a granular deprivation index based on zip code information our study adds to previous country-level ecological studies. In addition, recent studies on the impact of socioeconomic status on COVID-19 have shown that community-level deprivation indices are strongly associated with COVID-19 risk and mortality.33 34 However, it is still possible that differences in deprivation exists within communities. Further studies including information about household characteristics, built environment, or access to healthy foods are needed to expand these initial associations.
Our study adds to knowledge by investigating the association between diet quality and risk and severity of COVID-19 in a general population and in the context of social determinants of health. While our study supports the beneficial association of diet quality with COVID-19 risk and severity, particularly among individuals with higher deprivation, we cannot completely rule out the potential for residual confounding. Individuals who eat healthier diets are likely to share other features that might be associated with lower risk of infection such as the adoption of other risk mitigation behaviours, better household conditions and hygiene, or access to care. However, it is reassuring that our findings were consistent despite controlling for additional surrogate markers of SARS-CoV-2 infection such as mask wearing or community transmission rate, two of the most relevant factors associated with virus transmission and COVID-19 risk.35 These findings suggest that efforts to address disparities in COVID-19 risk and severity should consider specific attention to access to healthy foods as a social determinants of health.
We acknowledge several limitations. First, as an observational study, we are unable to confirm a direct causal association between diet and COVID-risk or infer specific mechanisms. Second, our study population was not a random sampling of the population. Although we tried to minimise potential selection bias, we recognise our participants are mainly white and less likely to live in deprived areas than the general population. Thus, the generalisability of our findings need to be confirmed in additional studies. Third, our results could be biased due to the time lapse between the dietary recalls, administered a few months after the relevant period of exposure (prepandemic). However, our sensitivity analyses in which we censored cases that had occurred before the administration of the diet survey showed consistent results. Fourth, the self-reported nature of the diet questionnaire is prone to measurement error and bias, and the use of a short food frequency survey could have further reduced the resolution of dietary data collected. More accurate dietary intake assessment methods such as the use of dietary intake biomarkers would be valuable in future studies,36 but also difficult to implement in large-scale and time-sensitive investigations. Fifth, outcomes rely on self-reported data. While it is possible that misclassification exists, there is an excellent agreement between self-report and test reports with 88% sensitivity and 94% specificity. In addition, the symptom-based algorithm provides similar estimates of COVID-19 prevalence and incidence as those reported from the Office for National Statistics Community Infection Survey. Sixth, we defined risk of severe COVID-19 according to reports of hospitalisation with oxygen support, which may not have captured more severe or fatal cases. We acknowledge that we were unable to include participants who may have died of COVID-19 before the administration of the diet questionnaire.
Conclusions
In conclusion, our data provide evidence that a healthy diet was associated with lower risk of COVID-19 and severe COVID-19 even after accounting for other healthy behaviours, social determinants of health and virus transmission measures. The joint association of diet quality with socioeconomic deprivation was greater than the addition of the risks associated with each individual factor, suggesting that diet quality may play a direct influence in COVID-19 susceptibility and progression. Our findings suggest that public health interventions to improve nutrition and poor metabolic health and address social determinants of health may be important for reducing the burden of the pandemic.
Data availability statement
The diet quality data used for this study are held by the department of Twin Research at Kings’ College London. The data can be released to bona fide researchers using our normal procedures overseen by the Wellcome Trust and its guidelines as part of our core funding (https://web.www.healthdatagateway.org/dataset/fddcb382-3051-4394-8436-b92295f14259). Zoe Platform data used in this study is available to researchers through UK Health Data Research using the following link:https://web.www.healthdatagateway.org/dataset/fddcb382-3051-4394-8436-b92295f14259. The diet quality data used for this study are held by the department of Twin Research at Kings’ College London. The data can be released to bona fide researchers using our normal procedures overseen by the Wellcome Trust and its guidelines as part of our core funding. We receive around 100 requests per year for our datasets and have a meeting three times a month with independent members to assess proposals. Application is via https://twinsuk.ac.uk/resources-for-researchers/access-our-data/. This means that the data needs to be anonymized and conform to GDPR standards.
Ethics statements
Patient consent for publication
Ethics approval
The study protocol was approved by the Mass General Brigham Human Research Committee (protocol 2020P000909) and King’s College London Ethics Committee (REMAS ID 18210, LRS-19/20–18210).
Acknowledgments
We express our sincere thanks to all of the participants who entered data into the app, including study volunteers enrolled in cohorts within the Coronavirus Pandemic Epidemiology (COPE) consortium. We thank the staff of Zoe Global, the Department of Twin Research at King’s College London and the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital for tireless work in contributing to the running of the study and data collection. This work was conducted using the Short Form FFQ tool developed by Cleghorn as reported in https://doi.org/10.1017/S1368980016001099 and listed in the Nutritools (www.nutritools.org) library.
References
Supplementary materials
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Footnotes
JM, ADJ and LHN are joint first authors.
TDS, SB and ATC are joint senior authors.
Twitter @Riudecanyenc, @EmilyLeemingRD, @DADrewPhD
Contributors JM, ADJ, LHN, ERL, TDS, SB and AC conceived the study design. JM, ADJ, ERL, MSG, JC, BM and SS contributed to the statistical analysis. All authors were involved in acquisition, analysis or interpretation of data. JM, LHN and DAD wrote the first draft of the manuscript. DAD, WW, SO, CJS, JW, PWF, TDS, SB and AC obtained funding. JM, ADJ and LHN provided administrative, technical or material support. TDS, SB and AC jointly supervised this work. All authors contributed to the critical revision of the manuscript for important intellectual content and approved the final version of the manuscript. The corresponding authors attest that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. TDS, SB and AC are joint last authors.
Funding National Institutes of Health (K01DK110267, K01DK120742, K23DK120899, K23DK125838, P30DK046200, P30DK40561, U01HL145386, R24ES028521), National Institute for Health Research (MR/M016560/1), UK Medical Research Council/Engineering and Physical Sciences Research Council (T213038/Z/18/Z), Wellcome Trust (WT212904/Z/18/Z, WT203148/Z/16/Z, T213038/Z/18/Z), Massachusetts Consortium on Pathogen Readiness (MassCPR-003), American Gastroenterological Association (AGA2021-5102), American Diabetes Association (7-21-JDFM-005) and Alzheimer’s Society (AS-JF-17-011).
Disclaimer The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Competing interests JW, CH, SS and JC are employees of Zoe Ltd. TDS, ERL and SB, area consultant to Zoe Ltd. DAD, JM and AC previously served as investigators on a clinical trial of diet and lifestyle using a separate mobile application that was supported by Zoe Ltd.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.